{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:30:40Z","timestamp":1785148240005,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":254,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020884","name":"ANID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Pharmacology and Drug Discovery"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.crphar.2022.100129","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:59:34Z","timestamp":1663246774000},"page":"100129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability by hypoxia"],"prefix":"10.1016","volume":"3","author":[{"given":"Esteban G.","family":"Figueroa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitor","family":"Caballero-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep R.","family":"Tic\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Mi\u00f1arro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nardi-Ricart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-367X","authenticated-orcid":false,"given":"Alejandro","family":"Gonz\u00e1lez-Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crphar.2022.100129_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.861714","article-title":"Advances in the role of endothelial cells in cerebral small vessel disease","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Neurol."},{"issue":"13","key":"10.1016\/j.crphar.2022.100129_bib3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","article-title":"Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases","volume":"13","author":"Ce\u00f1a","year":"2018","journal-title":"Nanomedicine (London, England)"},{"key":"10.1016\/j.crphar.2022.100129_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.omtn.2020.07.021","article-title":"Therapeutic potential of AntagomiR-23b for treating myotonic dystrophy","volume":"21","author":"Cerro-Herreros","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.crphar.2022.100129_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.omtn.2019.12.024","article-title":"MicroRNAs: possible regulatory molecular switch controlling the BBB microenvironment","volume":"19","author":"Chakraborty","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.crphar.2022.100129_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet.: TIG (Trends Genet.)"},{"issue":"1","key":"10.1016\/j.crphar.2022.100129_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2016.3503","article-title":"Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: \u039dew trends in the development of miRNA therapeutic strategies in oncology","volume":"49","author":"Gambari","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.crphar.2022.100129_bib8","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.celrep.2018.10.014","article-title":"Large differences in small RNA composition between human biofluids","volume":"25","author":"Godoy","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.crphar.2022.100129_bib9","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.94572","article-title":"Blood-brain barrier dysfunction in the detrimental brain function","author":"Gonzalez-Candia","year":"2021","journal-title":"Connectivity and Functional Specialization in the Brain"},{"key":"10.1016\/j.crphar.2022.100129_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.crphar.2022.100129_bib12","article-title":"Connectivity and functional specialization in the brain","author":"Heinbockel","year":"2021","journal-title":"BoD\u2013Books on Demand"},{"key":"10.1016\/j.crphar.2022.100129_bib13","article-title":"Gestational hypoxia and blood-brain barrier permeability: early origins of cerebrovascular dysfunction induced by epigenetic mechanisms","volume":"1267","author":"Herrera","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.crphar.2022.100129_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles","volume":"313","author":"Lee","year":"2019","journal-title":"J.\u00a0Contr. Release"},{"issue":"16","key":"10.1016\/j.crphar.2022.100129_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101090","article-title":"Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"issue":"626","key":"10.1016\/j.crphar.2022.100129_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay5686","article-title":"Endothelium-targeted deletion of the miR-15a\/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke","volume":"13","author":"Ma","year":"2020","journal-title":"Sci. Signal."},{"issue":"7","key":"10.1016\/j.crphar.2022.100129_bib17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/ijms18071356","article-title":"MicroRNA-210 suppresses junction proteins and disrupts blood-brain barrier integrity in neonatal rat hypoxic-ischemic brain injury","volume":"18","author":"Ma","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crphar.2022.100129_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-2289-6_1","article-title":"Cells of the blood\u2013brain barrier: an overview of the neurovascular unit in health and disease","author":"McConnell","year":"2022","journal-title":"The Blood-Brain Barrier"},{"key":"10.1016\/j.crphar.2022.100129_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.crphar.2022.100129_bib20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: from biomarkers to mediators of physiology and disease","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.crphar.2022.100129_bib22","article-title":"The blood\u2013retina barrier in health and disease","author":"O'Leary","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.crphar.2022.100129_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.crphar.2022.100129_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.pmbts.2018.04.002","article-title":"An Introduction to epigenetic mechanisms","volume":"158","author":"Radford","year":"2018","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"10.1016\/j.crphar.2022.100129_bib25","series-title":"Physiology, Pharmacology and Pathology of the Blood-Brain Barrier","first-page":"33","article-title":"New insights in the complexity and functionality of the neurovascular unit","author":"Schaffenrath","year":"2020"},{"issue":"6","key":"10.1016\/j.crphar.2022.100129_bib26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.biotechadv.2015.04.008","article-title":"Achieving successful delivery of oligonucleotides\u2014from physico-chemical characterization to in vivo evaluation","volume":"33","author":"Scomparin","year":"2015","journal-title":"Biotechnol. Adv."},{"issue":"6","key":"10.1016\/j.crphar.2022.100129_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"1","key":"10.1016\/j.crphar.2022.100129_bib28","first-page":"1","article-title":"miR-1303 regulates BBB permeability and promotes CNS lesions following CA16 infections by directly targeting MMP9","volume":"7","author":"Song","year":"2018","journal-title":"Emerg. Microb. Infect."},{"issue":"12","key":"10.1016\/j.crphar.2022.100129_bib29","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","article-title":"Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review","volume":"39","author":"Sosnik","year":"2014","journal-title":"Prog. Polym. Sci."},{"issue":"5","key":"10.1016\/j.crphar.2022.100129_bib30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/pharmaceutics14051073","article-title":"Different methods and formulations of drugs and vaccines for nasal administration","volume":"14","author":"Tai","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.crphar.2022.100129_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics10040269","article-title":"Blood-brain delivery methods using nanotechnology","volume":"10","author":"Teleanu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.crphar.2022.100129_bib32","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.118.310822","article-title":"MicroRNA-mediated therapy modulating blood\u2013brain barrier disruption improves vascular cognitive impairment","volume":"38","author":"Toyama","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.crphar.2022.100129_bib33","article-title":"Targeting microRNAs to regulate the integrity of the blood\u2013brain barrier","volume":"406","author":"Wang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.crphar.2022.100129_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"issue":"Suppl. 1","key":"10.1016\/j.crphar.2022.100129_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/15476286.2021.1950465","article-title":"Non-coding RNAs: the extensive and interactive regulators of the blood-brain barrier permeability","volume":"18","author":"Yang","year":"2021","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.crphar.2022.100129_bib36","first-page":"17","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.crphar.2022.100129_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J.\u00a0Contr. Release: official journal of the Controlled Release Society"},{"issue":"2","key":"10.1016\/j.crphar.2022.100129_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"}],"container-title":["Current Research in Pharmacology and Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257122000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590257122000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:47:59Z","timestamp":1762922879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590257122000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":35,"alternative-id":["S2590257122000499"],"URL":"https:\/\/doi.org\/10.1016\/j.crphar.2022.100129","relation":{},"ISSN":["2590-2571"],"issn-type":[{"value":"2590-2571","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability by hypoxia","name":"articletitle","label":"Article Title"},{"value":"Current Research in Pharmacology and Drug Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crphar.2022.100129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100129"}}